Tianjin Chase Sun Pharmaceutical Co Ltd Asset Resilience Ratio
Tianjin Chase Sun Pharmaceutical Co Ltd asset resilience ratio. Tianjin Chase Sun Pharmaceutical Co Ltd (300026) has an Asset Resilience Ratio of -0.89% as of December 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Tianjin Chase Sun Pharmaceutical Co Ltd (300026) liquidity interval to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Tianjin Chase Sun Pharmaceutical Co Ltd (2006–2023)
Asset resilience ratio of Tianjin Chase Sun Pharmaceutical Co Ltd from 2006 to 2023. This chart shows how Tianjin Chase Sun Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Read 300026 total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Tianjin Chase Sun Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see how large is Tianjin Chase Sun Pharmaceutical Co Ltd's balance sheet.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥-105.72 Million | -0.89% |
| Total Liquid Assets | CN¥-105.72 Million | -0.89% |
Asset Resilience Insights
- Limited Liquidity: Tianjin Chase Sun Pharmaceutical Co Ltd maintains only -0.89% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Tianjin Chase Sun Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio
Compare Tianjin Chase Sun Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jiangsu Hengrui Medicine Co Ltd
SHG:600276 |
Drug Manufacturers - Specialty & Generic | 0.16% |
|
Sandoz Group AG
SW:SDZ |
Drug Manufacturers - Specialty & Generic | 7.89% |
|
H Lundbeck A/S
CO:HLUN-B |
Drug Manufacturers - Specialty & Generic | -0.56% |
|
Changchun High & New Technology Industries Group Inc
SHE:000661 |
Drug Manufacturers - Specialty & Generic | 5.50% |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566 |
Drug Manufacturers - Specialty & Generic | 47.16% |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518 |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
Viyash Scientific Limited
NSE:SEQUENT |
Drug Manufacturers - Specialty & Generic | 0.08% |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153 |
Drug Manufacturers - Specialty & Generic | 1.81% |
Tianjin Chase Sun Pharmaceutical Co Ltd Asset Resilience Ratio by Year (2006–2023)
Tianjin Chase Sun Pharmaceutical Co Ltd asset resilience ratio by year from 2006 to 2023. The table below shows the annual Asset Resilience Ratio data for Tianjin Chase Sun Pharmaceutical Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | -0.89% | CN¥-105.72 Million ≈ $-15.47 Million |
CN¥11.84 Billion ≈ $1.73 Billion |
+0.36pp |
| 2022-12-31 | -1.25% | CN¥-158.00 Million ≈ $-23.12 Million |
CN¥12.63 Billion ≈ $1.85 Billion |
+0.33pp |
| 2021-12-31 | -1.58% | CN¥-183.67 Million ≈ $-26.88 Million |
CN¥11.61 Billion ≈ $1.70 Billion |
+0.20pp |
| 2020-12-31 | -1.78% | CN¥-181.52 Million ≈ $-26.56 Million |
CN¥10.18 Billion ≈ $1.49 Billion |
-1.09pp |
| 2019-12-31 | -0.69% | CN¥-58.31 Million ≈ $-8.53 Million |
CN¥8.43 Billion ≈ $1.23 Billion |
-0.28pp |
| 2018-12-31 | -0.41% | CN¥-30.99 Million ≈ $-4.53 Million |
CN¥7.48 Billion ≈ $1.10 Billion |
-0.53pp |
| 2006-12-31 | 0.12% | CN¥124.36K ≈ $18.20K |
CN¥105.62 Million ≈ $15.46 Million |
-- |
About Tianjin Chase Sun Pharmaceutical Co Ltd
Tianjin Chase Sun Pharmaceutical Co.,Ltd engages in the research and development, production, and sale of various pharmaceutical products in China and internationally. The company provides Chinese medicine formula granules, finished drugs, raw materials, medical devices and excipients, medical and health services, as well as smart supply chain for pharmaceuticals and medical devices. It serves th… Read more